logo
logo

Pfizer and BioNTech have asked US regulators to make their COVID-19 vaccine available to adolescents ages 12 to 15

avatar
Peter Williams
img
The vaccine showed "100 percent efficacy" and triggered a "robust antibody response" in trials with adolescents, the companies announced last month.
collect
0
avatar
Peter Williams
guide
Zupyak is a free content platform for publishing and discovering stories, software and startups.